[1] |
Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis[J]. Clin Microbiol Rev, 2020, 34(1): e00115-e00119.
|
[2] |
Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis[J]. Clin Microbiol Rev, 2012, 25(2): 264-296.
doi: 10.1128/CMR.05013-11
pmid: 22491772
|
[3] |
Luft BJ, Conley F, Remington JS, et al. Outbreak of central-nervous-system toxoplasmosis in western Europe and North America[J]. Lancet, 1983, 1(8328): 781-784.
pmid: 6132129
|
[4] |
Henriquez SA, Brett R, Alexander J, et al. Neuropsychiatric disease and Toxoplasma gondii infection[J]. Neuroimmunomodulation, 2009, 16(2): 122-133.
doi: 10.1159/000180267
pmid: 19212132
|
[5] |
Hsu PC, Groer M, Beckie T. New findings: depression, suicide, and Toxoplasma gondii infection[J]. J Am Assoc Nurse Pract, 2014, 26(11): 629-637
doi: 10.1002/2327-6924.12129
|
[6] |
Parlog A, Schlüter D, Dunay IR. Toxoplasma gondii-induced neuronal alterations[J]. Parasite Immunol, 2015, 37(3): 159-170.
doi: 10.1111/pim.12157
pmid: 25376390
|
[7] |
Pape K, Tamouza R, Leboyer M, et al. Immunoneuropsychiatry-novel perspectives on brain disorders[J]. Nat Rev Neurol, 2019, 15(6): 317-328.
|
[8] |
Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010[J]. PLoS Med, 2013, 10(11): e1001547.
doi: 10.1371/journal.pmed.1001547
|
[9] |
Ruderfer DM, Walsh CG, Aguirre MW, et al. Significant shared heritability underlies suicide attempt and clinically predicted probability of attempting suicide[J]. Mol Psychiatry, 2020, 25(10): 2422-2430.
doi: 10.1038/s41380-018-0326-8
|
[10] |
Wittenberg GM, Greene J, Vértes PE, et al. Major depressive disorder is associated with differential expression of innate immune and neutrophil-related gene networks in peripheral blood: a quantitative review of whole-genome transcriptional data from case-control studies[J]. Biol Psychiatry, 2020, 88(8): 625-637.
doi: 10.1016/j.biopsych.2020.05.006
|
[11] |
Kitaoka S. Inflammation in the brain and periphery found in animal models of depression and its behavioral relevance[J]. J Pharmacol Sci, 2022, 148(2): 262-266.
doi: 10.1016/j.jphs.2021.12.005
pmid: 35063142
|
[12] |
Innes S, Pariante CM, Borsini A. Microglial-driven changes in synaptic plasticity: a possible role in major depressive disorder[J]. Psychoneuroendocrinology, 2019, 102: 236-247.
doi: S0306-4530(18)30451-7
pmid: 30594100
|
[13] |
Li BJ, Yang W, Ge TT, et al. Stress induced microglial activation contributes to depression[J]. Pharmacol Res, 2022, 179: 106145.
doi: 10.1016/j.phrs.2022.106145
|
[14] |
Sochocka M, Diniz BS, Leszek J. Inflammatory response in the CNS: friend or foe?[J]. Mol Neurobiol, 2017, 54(10): 8071-8089.
doi: 10.1007/s12035-016-0297-1
pmid: 27889895
|
[15] |
Xu C, Zhang LD. Research advances of kynurenine pathway in depressive disorder[J]. Mil Med J Southeast China, 2022, 24(1): 69-72. (in Chinese)
|
|
(徐畅, 张利东. 犬尿氨酸代谢通路在抑郁症中的研究进展[J]. 东南国防医药, 2022, 24(1): 69-72.)
|
[16] |
Jeon SW, Kim YK. Inflammation-induced depression: its pathophysiology and therapeutic implications[J]. J Neuroimmunol, 2017, 313: 92-98.
doi: S0165-5728(17)30311-9
pmid: 29153615
|
[17] |
Sforzini L, Nettis MA, Mondelli V, et al. Inflammation in cancer and depression: a starring role for the kynurenine pathway[J]. Psychopharmacology, 2019, 236(10): 2997-3011.
doi: 10.1007/s00213-019-05200-8
pmid: 30806743
|
[18] |
Su WJ, Cao ZY, Jiang CL. Inflammatory mechanism of depression and its new strategy for diagnosis and treatment[J]. Acta Physiol Sin, 2017, 69(5): 715-722. (in Chinese)
|
|
(苏文君, 曹志永, 蒋春雷. 抑郁症的炎症机制及诊疗新策略[J]. 生理学报, 2017, 69(5): 715-722.)
|
[19] |
Sa QL, Mercier C, Cesbron-Delauw MF, et al. The amino-terminal region of dense granule protein 6 of Toxoplasma gondii stimulates IFN-γ production by microglia[J]. Microbes Infect, 2020, 22(8): 375-378.
doi: 10.1016/j.micinf.2019.12.003
|
[20] |
MacKenzie CR, Heseler K, Müller A, et al. Role of indoleamine 2, 3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines[J]. Curr Drug Metab, 2007, 8(3): 237-244.
pmid: 17430112
|
[21] |
Cheng JH, Xu X, Li YB, et al. Arctigenin ameliorates depression-like behaviors in Toxoplasma gondii-infected intermediate hosts via the TLR4/NF-κB and TNFR1/NF-κB signaling pathways[J]. Int Immunopharmacol, 2020, 82: 106302.
doi: 10.1016/j.intimp.2020.106302
|
[22] |
Lan HW, Lu YN, Zhao XD, et al. New role of sertraline against Toxoplasma gondii-induced depression-like behaviours in mice[J]. Parasite Immunol, 2021, 43(12): e12893.
|
[23] |
Jiang ZH, Zhou X, Li R, et al. Whole transcriptome analysis with sequencing: methods, challenges and potential solutions[J]. Cell Mol Life Sci, 2015, 72(18): 3425-3439.
doi: 10.1007/s00018-015-1934-y
pmid: 26018601
|
[24] |
Dubey JP, Laurin E, Kwowk OC. Validation of the modified agglutination test for the detection of Toxoplasma gondii in free-range chickens by using cat and mouse bioassay[J]. Parasitology, 2016, 143: 314-319.
doi: 10.1017/S0031182015001316
pmid: 26625933
|
[25] |
Li SY, He B, Yang CH, et al. Comparative transcriptome analysis of normal and CD44-deleted mouse brain under chronic infection with Toxoplasma gondii[J]. Acta Trop, 2020, 210: 105589.
doi: 10.1016/j.actatropica.2020.105589
|
[26] |
Pittman KJ, Aliota MT, Knoll LJ. Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection[J]. BMC Genomics, 2014, 15(1): 806.
doi: 10.1186/1471-2164-15-806
|
[27] |
He JJ, Ma J, Li FC, et al. Transcriptional changes of mouse splenocyte organelle components following acute infection with Toxoplasma gondii[J]. Exp Parasitol, 2016, 167: 7-16.
doi: 10.1016/j.exppara.2016.04.019
|
[28] |
Tanaka S, Nishimura M, Ihara F, et al. Transcriptome analysis of mouse brain infected with Toxoplasma gondii[J]. Infect Immun, 2013, 81(10): 3609-3619.
doi: 10.1128/IAI.00439-13
pmid: 23856619
|
[29] |
Smith K. Mental health: a world of depression[J]. Nature, 2014, 515(7526): 181.
|
[30] |
De-Miguel FF, Trueta C. Synaptic and extrasynaptic secretion of serotonin[J]. Cell Mol Neurobiol, 2005, 25(2): 297-312.
pmid: 16047543
|
[31] |
Salamone JD, Ecevitoglu A, Carratala-Ros C, et al. Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: exertion of effort vs. anhedonia[J]. Brain Res Bull, 2022, 182: 57-66.
doi: 10.1016/j.brainresbull.2022.01.019
pmid: 35151797
|
[32] |
Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments[J]. Trends Neurosci, 2008, 31(9): 464-468.
doi: 10.1016/j.tins.2008.06.006
pmid: 18675469
|
[33] |
Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression[J]. Trends Neurosci, 2013, 36(5): 305-312.
doi: 10.1016/j.tins.2013.01.005
pmid: 23384445
|
[34] |
Diviccaro S, Giatti S, Borgo F, et al. Treatment of male rats with finasteride, an inhibitor of 5 alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition[J]. Psychoneuroendocrinology, 2019, 99: 206-215.
doi: S0306-4530(18)30506-7
pmid: 30265917
|
[35] |
Suda K, Matsuda K. How microbes affect depression: underlying mechanisms via the gut-brain axis and the modulating role of probiotics[J]. Int J Mol Sci, 2022, 23(3): 1172.
doi: 10.3390/ijms23031172
|
[36] |
Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety[J]. Nat Neurosci, 2007, 10(9): 1089-1093.
doi: 10.1038/nn1971
pmid: 17726474
|
[37] |
Sakamoto S, Zhu XL, Hasegawa Y, et al. Inflamed brain: targeting immune changes and inflammation for treatment of depression[J]. Psychiatry Clin Neurosci, 2021, 75(10): 304-311.
doi: 10.1111/pcn.v75.10
|
[38] |
Innes S, Pariante CM, Borsini A. Microglial-driven changes in synaptic plasticity: a possible role in major depressive disorder[J]. Psychoneuroendocrinology, 2019, 102: 236-247.
doi: S0306-4530(18)30451-7
pmid: 30594100
|
[39] |
Li BJ, Yang W, Ge TT, et al. Stress induced microglial activation contributes to depression[J]. Pharmacol Res, 2022, 179: 106145.
doi: 10.1016/j.phrs.2022.106145
|
[40] |
Ogyu K, Kubo K, Noda Y, et al. Kynurenine pathway in depression: a systematic review and meta-analysis[J]. Neurosci Biobehav Rev, 2018, 90: 16-25.
doi: S0149-7634(18)30101-5
pmid: 29608993
|
[41] |
Egan CE, Cohen SB, Denkers EY. Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger[J]. Immunol Cell Biol, 2012, 90(7): 668-675.
doi: 10.1038/icb.2011.93
|